Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02836431 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children
A Phase 1 study of Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02836431 is a Phase 1 study of Heart Disease that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 18 participants, below the 2,046-participant average among 31 other Heart Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02836431, a Phase 1 study of Heart Disease, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is examining the absorption of the sedative dexmedetomidine (DEX) in the blood when given by nasal spray. The study will help us determine the best dosing amount for children undergoing sedation or anesthesia with DEX.
Conditions Studied
Interventions
- DRUG Dexmedetomidine 1mcg/kg Intranasal
- DRUG Dexmedetomidine 2mcg/kg Intranasal
- DRUG Dexmedetomidine 1mcg Intravenous
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02836431
The ClinicalTrials.gov registry entry for NCT02836431 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,046-participant average among 31 other Heart Disease trials with a reported enrollment target (99% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Disease appearing as the primary indexed condition, and to 3 interventions - of which Dexmedetomidine 1mcg/kg Intranasal is the first listed.
NCT02836431 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02836431 about?
NCT02836431 is a clinical study titled "Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children". This research study is examining the absorption of the sedative dexmedetomidine (DEX) in the blood when given by nasal spray. The study will help us determine the best dosing amount for children undergoing sedation or anesthesia with DEX.
What is the current status of trial NCT02836431?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2016-01. Estimated completion is 2018-04.
What conditions does trial NCT02836431 study?
This clinical trial studies the following conditions: Heart Disease.
What interventions are being tested in trial NCT02836431?
The interventions under investigation include: Dexmedetomidine 1mcg/kg Intranasal (DRUG), Dexmedetomidine 2mcg/kg Intranasal (DRUG), Dexmedetomidine 1mcg Intravenous (DRUG).
Who is sponsoring clinical trial NCT02836431?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02836431 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil
COMPLETED · Phase 1
-
Sildenafil in Single Ventricle Patients
COMPLETED · Phase 1
-
A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)
COMPLETED · Phase 1
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions
RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.